title: High risk of myelodysplastic syndrome and acute myeloid leukemia after 177Lu-octreotate PRRT in NET patients heavily pretreated with alkylating chemotherapy.
authors.affiliation: Service de gastro-entérologie et pancréatologieHôpital Beaujon, AP-HP, Université Paris Diderot, Clichy, France.
authors.forename: Bertrand
authors.initials: B
authors.lastname: Brieau
authors.affiliation: Service de gastro-entérologie et pancréatologieHôpital Beaujon, AP-HP, Université Paris Diderot, Clichy, France.
authors.forename: Olivia
authors.initials: O
authors.lastname: Hentic
authors.affiliation: Service de médecine nucléaireHôpital Beaujon, AP-HP, Université Paris Diderot, Clichy, France.
authors.forename: Rachida
authors.initials: R
authors.lastname: Lebtahi
authors.affiliation: Service de gastro-entérologie et pancréatologieHôpital Beaujon, AP-HP, Université Paris Diderot, Clichy, France.
authors.forename: Maxime
authors.initials: M
authors.lastname: Palazzo
authors.affiliation: Département de pharmacieHôpital Beaujon, AP-HP, Université Paris Diderot, Clichy, France.
authors.forename: Makrem
authors.initials: M
authors.lastname: Ben Reguiga
authors.affiliation: Service de gastro-entérologie et pancréatologieHôpital Beaujon, AP-HP, Université Paris Diderot, Clichy, France.
authors.forename: Vinciane
authors.initials: V
authors.lastname: Rebours
authors.affiliation: Service de gastro-entérologie et pancréatologieHôpital Beaujon, AP-HP, Université Paris Diderot, Clichy, France.
authors.forename: Frederique
authors.initials: F
authors.lastname: Maire
authors.affiliation: Service de gastro-entérologie et pancréatologieHôpital Beaujon, AP-HP, Université Paris Diderot, Clichy, France.
authors.forename: Pascal
authors.initials: P
authors.lastname: Hammel
authors.affiliation: Service de gastro-entérologie et pancréatologieHôpital Beaujon, AP-HP, Université Paris Diderot, Clichy, France.
authors.forename: Philippe
authors.initials: P
authors.lastname: Ruszniewski
authors.affiliation: Service d'hématologieHôpital Saint Louis, AP-HP, Université Paris Diderot, Paris, France pierre.fenaux@aphp.fr.
authors.forename: Pierre
authors.initials: P
authors.lastname: Fenaux
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D018906:Antineoplastic Agents, Alkylating / Q000627:therapeutic use*; D006801:Humans; D007414:Intestinal Neoplasms / Q000188:drug therapy*; D015470:Leukemia, Myeloid, Acute / Q000209:etiology*; D008875:Middle Aged; D009190:Myelodysplastic Syndromes / Q000209:etiology*; D018358:Neuroendocrine Tumors / Q000188:drug therapy*; D015282:Octreotide / Q000031:analogs & derivatives* / Q000627:therapeutic use; D010190:Pancreatic Neoplasms / Q000188:drug therapy*; D012306:Risk; D013274:Stomach Neoplasms / Q000188:drug therapy*; D055815:Young Adult
chemical_list: C554548:177Lu-octreotate; D018906:Antineoplastic Agents, Alkylating; D015282:Octreotide